Neurocrine Biosciences Inc (NBIX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | 339.4M | -125.2M | 54.4M | 266.4M | 389.9M | 130.3M | 194.9M | 352.9M |
Cash from Investing Activities | -177.1M | -42.1M | -168M | -265.3M | -467.1M | -55M | -83.2M | -58.5M |
Cash from Financing Activities | -234.3M | 8.2M | 11.1M | 29.9M | 65.3M | 69.9M | -223.1M | -196.7M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -106.18M | -94.33M | 101.36M | 152.05M | 228.5M | 256.5M | 339.4M | 389.9M |
Cash from Investing Activities | 112.86M | -250.87M | -242.92M | -211.07M | 4.1M | -130.2M | -177.1M | -467.1M |
Cash from Financing Activities | 2.39M | 516.65M | 29.53M | 27.31M | -157.8M | 27.4M | -234.3M | 65.3M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.